Jane A Dickerson1, Bonnie Cole, Jessie H Conta, Monica Wellner, Stephanie E Wallace, Rhona M Jack, Joe Rutledge, Michael L Astion. 1. From the Department of Laboratories (Drs Dickerson, Cole, Jack, Rutledge, and Astion and Mss Conta and Wellner) and the Division of Genetic Medicine (Dr Wallace), Seattle Children's Hospital, Seattle, Washington; the Departments of Laboratory Medicine (Drs Dickerson, Jack, Rutledge, and Astion) and Pathology (Dr Cole), University of Washington, Seattle; and the Department of Pediatrics, University of Washington School of Medicine, Seattle (Dr Wallace).
Abstract
CONTEXT: Tests that are performed outside of the ordering institution, send-out tests, represent an area of risk to patients because of complexity associated with sending tests out. Risks related to send-out tests include increased number of handoffs, ordering the wrong or unnecessary test, specimen delays, data entry errors, preventable delays in reporting and acknowledging results, and excess financial liability. Many of the most expensive and most misunderstood tests are send-out genetic tests. OBJECTIVE: To design and develop an active utilization management program to reduce the risk to patients and improve value of genetic send-out tests. DESIGN: Send-out test requests that met defined criteria were reviewed by a rotating team of doctoral-level consultants and a genetic counselor in a pediatric tertiary care center. RESULTS: Two hundred fifty-one cases were reviewed during an 8-month period. After review, nearly one-quarter of genetic test requests were modified in the downward direction, saving a total of 2% of the entire send-out bill and 19% of the test requests under management. Ultimately, these savings were passed on to patients. CONCLUSIONS: Implementing an active utilization strategy for expensive send-out tests can be achieved with minimal technical resources and results in improved value of testing to patients.
CONTEXT: Tests that are performed outside of the ordering institution, send-out tests, represent an area of risk to patients because of complexity associated with sending tests out. Risks related to send-out tests include increased number of handoffs, ordering the wrong or unnecessary test, specimen delays, data entry errors, preventable delays in reporting and acknowledging results, and excess financial liability. Many of the most expensive and most misunderstood tests are send-out genetic tests. OBJECTIVE: To design and develop an active utilization management program to reduce the risk to patients and improve value of genetic send-out tests. DESIGN: Send-out test requests that met defined criteria were reviewed by a rotating team of doctoral-level consultants and a genetic counselor in a pediatric tertiary care center. RESULTS: Two hundred fifty-one cases were reviewed during an 8-month period. After review, nearly one-quarter of genetic test requests were modified in the downward direction, saving a total of 2% of the entire send-out bill and 19% of the test requests under management. Ultimately, these savings were passed on to patients. CONCLUSIONS: Implementing an active utilization strategy for expensive send-out tests can be achieved with minimal technical resources and results in improved value of testing to patients.
Authors: Sarah V Clowes Candadai; Megan C Sikes; Jenny M Thies; Amanda S Freed; James T Bennett Journal: J Genet Couns Date: 2019-04 Impact factor: 2.537
Authors: Holly K Tabor; Paul L Auer; Seema M Jamal; Jessica X Chong; Joon-Ho Yu; Adam S Gordon; Timothy A Graubert; Christopher J O'Donnell; Stephen S Rich; Deborah A Nickerson; Michael J Bamshad Journal: Am J Hum Genet Date: 2014-07-31 Impact factor: 11.025
Authors: Jessica R Balcom; Katrina E Kotzer; Lindsey A Waltman; Jennifer L Kemppainen; Brittany C Thomas Journal: J Genet Couns Date: 2016-04-22 Impact factor: 2.537
Authors: Amanda S Freed; Sarah V Clowes Candadai; Megan C Sikes; Jenny Thies; Heather M Byers; Jennifer N Dines; Mesaki Kenneth Ndugga-Kabuye; Mallory B Smith; Katie Fogus; Heather C Mefford; Christina Lam; Margaret P Adam; Angela Sun; John K McGuire; Robert DiGeronimo; Katrina M Dipple; Gail H Deutsch; Zeenia C Billimoria; James T Bennett Journal: J Pediatr Date: 2020-06-15 Impact factor: 4.406
Authors: Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd Journal: Genet Med Date: 2020-06-24 Impact factor: 8.822